|
|
|
|
 |
 |
Hi ,
|
Join me at 8 am PT today for our live webinar covering the annual Synthetic Biology Investment Report! You can register here.
|
 |
On the latest episode of the SynBioBeta podcast - I sit down with my good friend Eben Bayer, the CEO of Ecovative, a trailblazing company leading the charge in sustainable materials from mycelium. We'll delve into Ecovative's journey, cutting-edge agricultural tech in mushroom growing, and the potential of new mycelium crops in consumer goods. Plus, we'll explore Ecovative's innovative use of AI and digital twins.
|
 |
Eben Bayer is not only the CEO of Ecovative but also the Co-founder of My Forest Foods and an inventor with 64+ patents. As an entrepreneur, inventor, and futurist, Eben advocates for sustainable stewardship of Spaceship Earth and advises environmental startups worldwide. You won't want to miss this enlightening conversation. Listen now.
Thank you to this week’s sponsor, Swissnex, the Swiss global network connecting Switzerland and the world in education, research, and innovation. Their mission is to
support their partners' outreach and active engagement in the international exchange of knowledge, ideas, and talents, strengthening Switzerland's profile as a world-leading innovation hotspot.
|
 |
At The Global Synthetic
Biology Conference, we gather engineers, investors, innovators, and entrepreneurs across a broad base of industries and company sizes who are committed to using biology to build a better world. Here are some of the currently registered attendees who you can meet and collaborate with:
Birch Biosciences, Howard Hughes Medical Institute Janelia Research Campus, Chan Zuckerberg Initiative, Lonza, lululemon, Sterling Bio Machines, Hamilton Company, AgFunderNews, L'Oreal Research & Innovation, Abbott Laboratories, The Harrison Group, The Estee Lauder Companies, X Capital, Ginkgo Bioworks, MelaTech, Alkem labs, Unilever, Novonesis, bitBiome, Lewis & Clark AgriFood, FUJIFILM Holdings America Corporation
|
New speakers announced:
|
 |
New Sponsors & Exhibitors coming to SynBioBeta 2024:
|
Yourgene Health is an integrated technologies and services business enabling the delivery of genomic medicine.
Bio Base Europe Pilot Plant is an independent, state-of-the-art facility that operates from a laboratory level to a multi-ton scale.
Conagen is advancing how natural products are manufactured with molecule-per-molecule precision and customization.
Ailurus is a biocomputer company that establishes architecture and language to program biology.
VTT is a visionary research and innovation partner for companies and society. VTT is one of Europe's leading research institutions.
Cemvita uses industrial biotech to recover natural resources without environmental damage.
GeneFrontier provides protein engineering and drug discovery products, services, and technologies.
CJ Foods has been leading the food industry in Korea for more than 60 years.
If you are interested in having a space on the floor, please contact our team here.
|
|
|
| Register now |
|
|
|
|
|
|
|
|
Insights (Exclusive Content):
|
Digital Twins to Advance Biomanufacturing: Shannon Hall is the CEO and co-founder of Pow.Bio, a Berkeley-based startup with a mission to revolutionize the biomanufacturing industry and the fermentation process. She thinks the industry needs a complete mindset change to achieve the cost and production efficiencies to make a true
bioeconomy possible.
|
 |
Using new technologies for bioproduction will be discussed extensively during the SynbioBeta 2024 Conference, where Shannon Hall is the Chair of the Biomanufacturing Scale-Up track.
|
Industry News:
|
BioAge Announces $170 Million Oversubscribed Series D Financing to Accelerate Development of Obesity and Metabolic Disease Therapeutics. BioAge spoke during our longevity session at SynBioBeta last year. (Press release)
Driving Decarbonization: Again Partners with HELM for Global Sustainable Chemical Distribution. Climate tech startup Again announced a new partnership with the global chemicals organization HELM to distribute and sell its inaugural product, acetic acid.
TurtleTree Achieves Landmark Vegan Certification for Sustainable Lactoferrin: TurtleTree, a trailblazer in sustainable nutrition, and Vegan Action, the foremost vegan certification provider in the U.S., have jointly announced the official vegan certification of TurtleTree's animal-free sustainable
lactoferrin, LF+. You can see Fengru Lin speak at SynBioBeta this year!
Ginkgo Bioworks Hosts Congressional Members to Discuss U.S. Bioeconomy and National Security. The event featured a comprehensive tour of Ginkgo's expansive facility and insightful discussions highlighting its pivotal role as a provider of biotechnology services to companies of all sizes
across various sectors of the economy. You can hear Jason Kelly talk about the US Bioeconomy at SynBioBeta this year.
Intellia Therapeutics and ReCode Therapeutics Forge Alliance to Pave the Way for Innovative Gene Editing Treatments for Cystic Fibrosis. CF, a genetic disorder stemming from mutations in the CFTR gene, triggers the accumulation of thick mucus in
vital organs like the lungs and digestive system.
Oxitec Establishes New R&D Hub in Scotland to Combat Invasive Cattle Ticks. The facility, situated within the University of Edinburgh's esteemed Roslin Institute, will be the epicenter for crafting a groundbreaking solution to tackle the world's most destructive cattle pest, the Asian blue tick.
ProfoundBio Raises $112 Million in Series B Financing to Advance Breakthrough Cancer Therapies. ProfoundBio, a pioneering clinical-stage biotechnology firm specializing in antibody-drug conjugate (ADC) therapeutics, has announced the successful closure of an oversubscribed $112 million
Series B financing round.
eGenesis and PorMedTec Achieve Milestone: Genetically Engineered Porcine Donors Produced in Japan. This collaboration represents a pivotal moment in medical science. eGenesis provided PorMedTec with genetically engineered porcine cells, which were used in the cloning process through
somatic cell nuclear transfer.
|
Other news:
|
|
Who's hiring?
|
|
|
|
|
|
|
|
|
|
